Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | Viking Therapeutics, Inc. | MACARTNEY LAWSON
(Director) |
S | Common Stock, par value $0.00001 per share | D | 2000 | $68.67 - $68.67 | $137,333 |
| 2024-11-08 | Viking Therapeutics, Inc. | MACARTNEY LAWSON
(Director) |
M | Common Stock, par value $0.00001 per share | A | 2000 | $5.80 - $5.80 | $11,600 |
| 2024-10-28 | Viking Therapeutics, Inc. | ZANTE GREG
(Chief Financial Officer) |
S | Common Stock, par value $0.00001 per share | D | 131687 | $74.56 - $81.44 | $10,089,159 |
| 2024-10-28 | Viking Therapeutics, Inc. | ZANTE GREG
(Chief Financial Officer) |
M | Common Stock, par value $0.00001 per share | A | 94001 | $4.68 - $8.52 | $704,281 |
| 2024-10-25 | Viking Therapeutics, Inc. | Rouan Sarah Kathryn
(Director) |
S | Common Stock, par value $0.00001 per share | D | 11000 | $80.89 - $80.89 | $889,790 |
| 2024-10-25 | Viking Therapeutics, Inc. | Rouan Sarah Kathryn
(Director) |
M | Common Stock, par value $0.00001 per share | A | 11000 | $4.88 - $4.88 | $53,680 |
| 2024-10-25 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
S | Common Stock, par value $0.00001 per share | D | 16000 | $79.50 - $79.50 | $1,272,000 |
| 2024-10-25 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
M | Common Stock, par value $0.00001 per share | A | 16000 | $4.48 - $4.48 | $71,680 |
| 2024-09-20 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
S | Common Stock, par value $0.00001 per share | D | 10300 | $69.50 - $69.50 | $715,850 |
| 2024-09-20 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
M | Common Stock, par value $0.00001 per share | A | 10300 | $1.19 - $1.19 | $12,257 |
| 2024-09-20 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
S | Common Stock, par value $0.00001 per share | D | 216130 | $70.43 - $71.98 | $15,308,552 |
| 2024-09-20 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
M | Common Stock, par value $0.00001 per share | A | 166130 | $7.77 - $7.77 | $1,290,830 |
| 2024-08-21 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
S | Common Stock, par value $0.00001 per share | D | 1000 | $69.90 - $69.90 | $69,900 |
| 2024-08-21 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
M | Common Stock, par value $0.00001 per share | A | 1000 | $7.77 - $7.77 | $7,770 |
| 2024-08-21 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
S | Common Stock, par value $0.00001 per share | D | 5700 | $69.72 - $69.72 | $397,430 |
| 2024-08-21 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
M | Common Stock, par value $0.00001 per share | A | 5700 | $1.19 - $1.19 | $6,783 |
| 2024-08-19 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
S | Common Stock, par value $0.00001 per share | D | 112870 | $65.33 - $67.12 | $7,426,507 |
| 2024-08-19 | Viking Therapeutics, Inc. | Lian Brian
(President & CEO) |
M | Common Stock, par value $0.00001 per share | A | 112870 | $7.77 - $7.77 | $876,999 |
| 2024-08-19 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
S | Common Stock, par value $0.00001 per share | D | 16000 | $60.01 - $64.88 | $995,451 |
| 2024-08-19 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
M | Common Stock, par value $0.00001 per share | A | 16000 | $3.33 - $3.33 | $53,280 |
| 2024-08-14 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
S | Common Stock, par value $0.00001 per share | D | 20786 | $57.52 - $58.37 | $1,195,736 |
| 2024-08-14 | Viking Therapeutics, Inc. | SINGLETON J MATTHEW
(Director) |
M | Common Stock, par value $0.00001 per share | A | 20786 | $8.00 - $8.00 | $166,288 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |